| N |
| N Nafissi |
- |
Genotyping of Hemophilia B in Iran by SSCP and Sequencing |
| Nachtrodt G |
- |
Cranial Epidural Bleeding in a Child with Congenital Afibrinogenaemia, Management and Long-Term-Prophylaxis with a Fibrinogen Concentrate |
| Nadal MV |
- |
Evaluation of Fibrinolytic Activity and Major Hemorrhages in Probable Type 1 Von Willebrand Disease |
| Nadar SK |
- |
Circulating Endothelial Cells in Acute Ischaemic Stroke |
| Nadir Y |
- |
Effect of Heparanase on TF Expression and TFPI Release |
| Naeke A |
- |
In vitro Determination of Platelet Function in Whole Blood from Obese Children and Adolescents |
| Nafissi N |
- |
Carrier Testing of Hemophilia B by SSCP and Sequencing in One Iranian Family |
| Nafissi N |
- |
Carrier Detection and Prenatal Diagnosis of Two Short Tandem Repeats within Factor VIII Gene in Iranian Population |
| Nagahams Y |
- |
Development of a Latex Agglutination Test for the Measurement of Elastase-Digests of Fibrin in Plasma and Its Application to Clinical Samples |
| Nagai R |
- |
Significance of the Transcription Factor KLF5 in Cardiovascular Remodeling |
| Nagaike K |
- |
Protein C Inhibitor Plays a Role as a Potent Regulator of Activated Hepatocyte Growth Factor Activator |
| Naganuma H |
- |
Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of CS-747 (Prasugrel, LY640315) and Clopidogrel in Healthy Subjects |
| |
- |
Superior Inhibition of Platelet Aggregation Following a Loading Dose of CS-747 (Prasugrel, LY640315) Versus Clopidogrel: Correlation with the Pharmacokinetics of Active Metabolite Generation |
| Nagasawa T |
- |
CS-747 (Prasugrel, LY640315) Produces Potent and Sustained Platelet Inhibitory Effects in Dogs and Monkeys During Multiple Dosing That Are Enhanced by Co-administration of Aspirin |
| |
- |
Observation of in vivo Proplatelet formation During Thrombopoiesis. Apoptosis is Not involved in the Process of Proplatelet formation |
| Nagashima M |
- |
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Regulates Activated Complement C5a in vivo |
| Nagaswami S |
- |
Delayed FPA Release from Homophenotypic Aa 16 H (Fibrinogen Kingsport): Major b Fibrin Epitope Role in Clotting Times and Branching |
| Nagatsuka K |
- |
Identification of Genetic Variations in Genes Comprised in Vitamin K-dependent g-Carboxylation System |
| Nagea M |
- |
Muscular Crushing-‘Thrombotic Disorder’ of the Injured Limb |
| |
- |
Arterial Thrombosis Complicating Limb Trauma |
| Nagel D |
- |
Serum Levels of Soluble Tissue Factor and the Risk of Future Coronary Artery Disease; The EPIC-Norfolk Prospective Population Study |
| Naglieri E |
- |
Risk Factors for CVC-Associated Thrombosis in Cancer Patients: Analysis of the ETHIC Study |
| Nagy JA |
- |
Angiogenesis Update 2005: How Tumors Make Bad Blood Vessels |
| Nagy E |
- |
Modeling VWF Catabolism Predicts the Multimer Pattern and Subunit Degradation in VWD Vicenza, Type 1, Type 2A, and Healthy Controls after DDAVP Infusion |
| Nagy Jr B |
- |
Comparative Evaluation of FXIIIA and P-selectin Expression on the Surface of Thrombin-activated Platelets and Microparticles |
| Naidu K |
- |
Cocoa Beverage Shows Platelet Inhibition Activity, Depressing Platelet Activation Antigens CD61, CD62p and PAC1 and Extending the PFA 100 Closure Time |
| Naik MU |
- |
Interaction of CIB1 and GPIIb/IIIa Is Required for Activation of Src and FAK During Outside-In Signaling |
| Naik UP |
- |
Interaction of CIB1 and GPIIb/IIIa Is Required for Activation of Src and FAK During Outside-In Signaling |
| |
- |
Identification and Characterization of Novel Members of the Calcium and Integrin Binding Protein Family |
| Naik MU |
- |
Junctional Adhesion Molecule-A Induced Endothelial Cell Migration on Vitronectin is Integrin avb3-Specific |
| Naik UP |
- |
Junctional Adhesion Molecule-A Induced Endothelial Cell Migration on Vitronectin is Integrin avb3-Specific |
| Naik MU |
- |
Essential Role of Junctional Adhesion Molecule-A in bFGF-Induced Angiogenesis |
| Naik UP |
- |
Essential Role of Junctional Adhesion Molecule-A in bFGF-Induced Angiogenesis |
| Naik UP |
- |
Junctional Adhesion Molecule-A: A Key Regulator of Both bFGF and VEGF-Induced Angiogenic Signaling |
| Naik MU |
- |
Junctional Adhesion Molecule-A: A Key Regulator of Both bFGF and VEGF-Induced Angiogenic Signaling |
| Naik UP |
- |
Crystal Structure of Calcium- and Integrin-Binding Protein 1: Insights to a Novel Mechanism of Action |
| Naik UP |
- |
Junctional Adhesion Molecule-A a Key Regulator of Both bFGF and VEGF-Induced Angiogenic Signaling |
| Naik MU |
- |
Junctional Adhesion Molecule-A a Key Regulator of Both bFGF and VEGF-Induced Angiogenic Signaling |
| Naimushin YA |
- |
Ability of Different Glycoprotein IIb-IIIa (aIIb/b3-Integrin) Ligands to Support Platelet Aggregation and Release Reaction Induced by Activating Anti-LIBS Antibody |
| Nair SC |
- |
Molecular Characterization of Haemophilia B: 17 Novel Mutations in Patients of Indian Origin |
| Nair P |
- |
Unusual Thrombophilic Manifestations of Protein C Deficiency, Factor V Leiden and Antiphospholipid Syndrome From Sultanate of Oman |
| Nair SC |
- |
Successful Surgical Haemostasis in Patients with von Willebrand Disease with Koate®DVI |
| Nair SC |
- |
Data From APTT Clot Curves of Automated Photo-Optical Coagulometers Correlates Better with Heterogeneity of Clinical Presentation in Severe Hemophilia A than FVIII: C Levels |
| Nair S |
- |
Thrombin Generation in Haemophilia A Patients Does Not Necessarily Correlate with Levels of Factor VIII Detected Using Standard Factor VIII Potency Assays: A Comparative Analysis of Pre- and Post-Infusion Patients Plasmas Using Fluorogenic and Clotting Thrombin Generation Tests |
| Nair SC |
- |
Ristocetin Cofactor (VWF:Rco) Assay – A Comparison of a Rapid Automated Method on ACL10000 Coagulometer and Conventional Aggregometry |
| Naito S |
- |
Factor VII Arg277His Mutation Induced Discrepancy of Factor VII Activity Levels Using Tissue Factor from Different Sources |
| Najmabadi H |
- |
Study of Genetic Risk Factors for Cardiovascular Disease in the Iranian Population by Means of Reverse-Hybridization Teststrips |
| Naka H |
- |
Phenotype Correction of Hemophilia A Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene |
| |
- |
Phenotype Correction of Hemophilia a Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene |
| Naka D |
- |
Protein C Inhibitor Plays a Role as a Potent Regulator of Activated Hepatocyte Growth Factor Activator |
| Nakabayashi T |
- |
Factor VII Arg277His Mutation Induced Discrepancy of Factor VII Activity Levels Using Tissue Factor from Different Sources |
| Nakagata N |
- |
Antithrombin Failed to Attenuate Inflammatory Responses in Congenital Calcitonin Gene-Related Peptide Deficient Mice Subjected to Hepatic Ischemia/Reperfusion |
| Nakagawa K |
- |
Paracrine Loop between VEGF-C/Flt-4 and PDGF-BB/PDGFR-Beta Systems Contributes Therapeutic Angiogenesis Using FGF-2 Gene Transfer in Ischemic Hind Limbs |
| Nakagawa S |
- |
Pulmonary Thromboembolism in Cancer Patients Autopsied in a Japanese General Hospital |
| Nakahara K |
- |
Clinical Importance of Measurement of Soluble Fibrin Monomer-Fibrinogen Complex in Patients with Disseminated Intravascular Coagulation Syndrome and Hypercoagulable State |
| Nakahara M |
- |
Endoplasmic Reticulum-Associated Degradation of Naturally Occurring Protein C and Plasmin Inhibitor Mutants |
| Nakahara K |
- |
A Novel Molecular Marker of Soluble Fibrin Monomer-Fibrinogen Complex Is Quite Valuable for Diffrential Diagnosis of Septic Pneumonia and Simple Pneumonia |
| Nakakuma H |
- |
A Novel Molecular Marker of Soluble Fibrin Monomer-Fibrinogen Complex Is Quite Valuable for Diffrential Diagnosis of Septic Pneumonia and Simple Pneumonia |
| |
- |
Clinical Importance of Measurement of Soluble Fibrin Monomer-Fibrinogen Complex in Patients with Disseminated Intravascular Coagulation Syndrome and Hypercoagulable State |
| Nakamura S |
- |
Tissue Factor Expression in Human Neutrophils |
| Nakamura M |
- |
Physician Practices for Providing Venous Thromboembolism Prophylaxis to Hospitalized Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) |
| Nakamura S |
- |
Epigenetic Regulation of Tissue Factor Gene Expression |
| Nakamura M |
- |
The Influence of Previous or Currently Active Cancer on Venous Thromboembolism Prophylaxis Prescribing Practices in Acutely Ill Medical Patients |
| |
- |
Observed Rates of Clinically Apparent Venous Thromboembolism and Death Due to Pulmonary Embolism Among Unselected Hospitalized Acutely Ill Medical Patients Compared to Rates Predicted from Clinical Trials |
| Nakanishi Y |
- |
CS-747 (Prasugrel, LY640315), a Novel Antiplatelet Agent, Inhibits Arterial Thrombosis Through Selective Blockade of Platelet P2Y12 Receptors |
| |
- |
Active Metabolites of CS-747 (Prasugrel, LY640315) and Clopidogrel Show Similar in vitro P2Y12 Receptor Blockade But Greater in vivo Potency of CS-747 |
| Nakano T |
- |
Paracrine Loop between VEGF-C/Flt-4 and PDGF-BB/PDGFR-Beta Systems Contributes Therapeutic Angiogenesis Using FGF-2 Gene Transfer in Ischemic Hind Limbs |
| Nakao S |
- |
HMG-CoA Reductase Inhibitors Reduce the Synthesis of Tissue Factor and Factor VII and Increase the Synthesis of Tissue Factor Pathway Inhibitor in Human Mononuclear Cells |
| |
- |
Roles of Adhesion Molecules in the Development of Antiphospholipid Syndrome: Key Roles of E-selectin in the Induction of Antiphospholipid Antibodies |
| |
- |
Functional Analysis o Two Recombinant Missense Mutant Factor XI, F221S ad C212R |
| Nakashima T |
- |
Rational of Pharmacological Effect of a Combination of FVIIa and FX for Hemophilia with Inhibitors |
| |
- |
Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice |
| Nakatomi Y |
- |
Rational of Pharmacological Effect of a Combination of FVIIa and FX for Hemophilia with Inhibitors |
| Nakaya SM |
- |
ELISA for Detecting Immune Responses to Factor VIII |
| Nakaya SM |
- |
Severe Hemophilia B Due to a 6 kb Deletion Including Exon 4, Due to Non-Homologous Recombination and Associated with Dysfunctional Protein Missing the First EGF-like Domain |
| Nakayama H |
- |
Standardization of Assays for Plasma Fibrin-Fibrinogen Degradation Products |
| Nakazawa F |
- |
Extracellular Nucleic Acids Serve as Novel Cofactors for Blood Coagulation Via Contact Pathway Activation |
| Nalbone G |
- |
The TNF Alpha Converting Enzyme (TACE/ADAM17) Is Expressed in the Atherosclerotic Lesion of ApoE-deficient Mice |
| Namba M |
- |
Elevated Platelet Delivered Microparticles and Lesion Morphology in Acute Coronary Syndrome |
| NamliGücükoglu SA |
- |
Short-Course Use of Recombinant Factor VIIa in a Hemophilia Patient with Inhibitor Undergoing Cataract Surgeries |
| Nanda V |
- |
Heteromeric and Homomeric Transmembrane Domain Associations Regulate aIIbb3 Function |
| Naoe T |
- |
Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice |
| Naofumi H |
- |
Decreased Contribution of ADP and Thromboxane A2 to Aggregation Induced by Collagen in Platelets from Chediak-Higashi Syndrome Affected Cattle |
| Naoumova RP |
- |
Reduced Expression of ABCA1 and A Novel Missense Mutation That Results in Altered Protein Trafficking Underlie Scott Syndrome |
| Naparstek E |
- |
Enrichment of Early Megakaryocyte Progenitors and Their Ex-Vivo Expansion for Transplantation |
| Napoleone E |
- |
Inhibition of the Renin-Angiotensin System Modulates the Procoagulant/Fibrinolytic Potential of Human Breast Carcinoma Cells |
| |
- |
Effect of Paclitaxel on the Coagulation/Fibrinolytic System Pattern in Cancer and Host's Tumor-Associated Cells |
| Nar H |
- |
In vivo Anticoagulant, Antithrombotic and Anti-inflammatory Efficacy of BIBT 986, a Novel Synthetic Active Site Dual Inhibitor of Thrombin and Factor Xa |
| |
- |
In Vitro Pharmacological Characterization of BIBT 986, A Novel Synthetic Active Site Dual Inhibitor of Thrombin and Factor Xa |
| Naran NH |
- |
The Molecular Characterization of Apo E and Its Association with Serum and Platelet Membrane Lipids in Familial Hypercholesterolaemia (FH) |
| Naran NH |
- |
Platelet Glycoprotein IIIa (PlA1/A2) and Plasminogen Activator Inhibitor-1 (4G/5G) Polymorphisms as Risk Factors for Coronary Artery Disease |
| |
- |
The Prevalence of the Human Glycoprotein PC-1 Gene Polymorphism (K121Q) and Its Association with Type II Diabetes and Insulin Resistance in the South African Inter Ethnic Population |
| Narbaitz M |
- |
Catastrophic Antiphospholipid Syndrome and Kikuchi-Fujimoto Disease: The First Case Reported |
| Nardi M |
- |
Utility Of D-Dimer in the Diagnosis of Deep Venous Thrombosis in Hospitalized Patients at High Risk of Venous Thromboembolism |
| Naritomi H |
- |
Identification of Genetic Variations in Genes Comprised in Vitamin K-dependent g-Carboxylation System |
| Narula J |
- |
Real-Time in Vivo Imaging of the Kinetics of Macrovascular Thrombus Formation |
| |
- |
Down-regulation of Tissue Factor Surface Expression by Annexin A5: a New Anticoagulant Mechanism |
| Nascimento AL |
- |
Effects of Leptospiral Proteins on Human Endothelial Cells |
| Naseem M |
- |
Regulation of Platelet Guanylyl Cyclase by Collagen: Evidence That Glycoprotein-VI Mediates Platelet Nitric Oxide Synthesis in Response to Collagen |
| Naseem KM |
- |
Platelet Nitric Oxide Synthase (NOS) Is Negatively Regulated by Tyrosine Phosphorylation: A Novel Mechanism of eNOS Regulation |
| Nash G |
- |
A Novel Cytokine Mediated Route of Promoting the Adhesion of Platelets to Endothelial Cell Monolayers |
| Naslin D |
- |
Experience of Surgery with Continuous Infusion at Karolinska University Hospital in Patients With Hemophilia A and B, von Willebrand'S Disease and FVII-Deficiency |
| Natesha B |
- |
Heritability of Quantitative Phenotypes: Lipids, Coagulation, Pro-Inflammatory, Cell Adhesion and Anthropometric Markers in the Presence or Absence of Coronary Artery Disease (CAD) in Parents |
| |
- |
Heritability of Triglyceride and Relationship with Sac-1 Polymorphism in 3'-Untranslated Region (UTR) of Apolipoprotein CIII Gene: Linkage of Apolipoprotein CIII Locus (Chromosome 11 q23) and Association of Variant Allele with Coronary Artery Disease (CAD) |
| |
- |
Relationship Among Antibody Against Cytomegalovirus (CMV), Plasma Interleukin-6 (IL-6) and Coronary Artery Disease (CAD) – Preliminary Findings of the Indian Atherosclerosis Research Study (IARS) |
| |
- |
Expression of Interleukin-1 (IL-1) Alpha Gene and Circulating Levels of Interleukin-6 (IL-6) and Plasminogen Activator Inhibitor-1 (PAI-1): Preliminary Findings of the Indian Atherosclerosis Research Study (IARS) |
| Naud S |
- |
Attitudes about Genetic Testing for Thrombophilia in a Large Family with Heritable Protein C Deficiency |
| Naumann E |
- |
Intravenous Leiomyosarcoma Presenting As Iliac Vein Thrombosis |
| Naumnik B |
- |
Novel Determinants of Increased Plasma Tissue Factor Level in Maintenance Hemodialysis Patients |
| Naumnik B |
- |
Plasmatic and Urinary Tissue Factor (TF) And Its Inhibitor (TFPI) Do Not Reflect the Activity of Human Chronic Glomerulonephritis |
| Naumnik, Mysliwiec M |
- |
Prolonged Euglobulin Clot Lysis Time does not Always Indicate Impaired Fibrinolysis in Chronic Hemodialysis Patients |
| Navaneetham D |
- |
Inhibition of the Catalytic Domain of Factor XIa (FXIac) by the Kunitz Protease Inhibitory Domain of Protease Nexin 2 (PN2KPI) Is Mediated by Interactions Between Lys192 of FXIac and Pro13 of PN2KPI and Between Tyr5901 of FXIac and Arg20 of PN2KPI |
| Navaneetham D |
- |
Mutational Analysis of the Kunitz Protease Inhibitor (KPI) Domain of Protease Nexin-2 (PN2) Reveals Specificity for Regulation of Factor XIa (FXIa) in Contrast to Other Coagulation Target Proteases |
| Navarette M |
- |
Factor X Deficiency: Clinical Manifestation of 102 Subjects with Mutations in Factor 10 Gene |
| Navarro S |
- |
Influence of Polymorphisms in the Endothelial Protein C Receptor Gene on the Risk of Venous Thromboembolism in Carriers of the Factor V Leiden Mutation |
| Navarro S |
- |
Protein CValencia: Symptomatic Type II Protein C Deficiency Associated with a Mutation in the Gla Domain (Glu16 to Lys) |
| Navarro C |
- |
Microparticles from Smooth Muscle Cells Induce Endothelial Dysfunction, a Phenomenon Prevented by Glycoprotein IIb/IIIa Antagonists |
| Navarro S |
- |
The C1418T Polymorphism in the Thrombomodulin Gene is Associated with Increased Levels of Circulating Activated Protein C and with Reduced Risk of Venous Thromboembolism |
| Navarro S |
- |
Decreased Plasma Levels of Activated Protein C in Young Survivors of Myocardial Infarction: Relationship with the Extent of Coronary Artery Disease |
| Navis GJ |
- |
Absolute Risk of Arterial Thromboembolism (ATE) Associated with Nephrotic Syndrome. Results from the Coltrane Study |
| |
- |
Absolute Risk of Venous Thromboembolism (VTE) Associated with Nephrotic Syndrome. Results from the Coltrane Study |
| Nawroth PP |
- |
Hyperglycemia Induces Loss of the Protective Endothelial Thrombomodulin Protein C System |
| |
- |
The Junctional Adhesion Molecule-C Promotes Neutrophils Transendothelial Migration in vitro and in vivo |
| Naylor AR |
- |
Metabolism of Arachidonic Acid through 12-LOX in Platelets May Account for Transient Aspirin Resistance Linked to Treatment with Heparin |
| Ndonwi M |
- |
Role of Gamma-Carboxyglutamic Acid (Gla) and First Epidermal Growth Factor (EGF1)-Like Domains of Factor IX (FIX) in Physiologic Coagulation |
| Neal B |
- |
Associations of Inflammatory and Haemostatic Variables with the Risk of Recurrent Stroke |
| Neals M |
- |
The Use of Temporary IVC Filters for the Prevention of Pulmonary Embolism in High Risk Patients |
| Nedelcu DE |
- |
Muscular Crushing-‘Thrombotic Disorder’ of the Injured Limb |
| Nedevsky J |
- |
Treatment of Congenital Coagulation Disorders in Countries with Limited Financial Resources – Bulgarian Experience |
| Needham J |
- |
Intravenous DDAVP Associated Reduction in Fibrinogen – Implications for Patients with Von Willebrand's Disease or Haemophilia A with Borderline Fibrinogen Levels Requiring Invasive Procedures |
| |
- |
Effect on the Tissue Factor Pathway of Cessation of Warfarin Anticoagulant Therapy |
| |
- |
Influence of the Tissue Factor Pathway on Initiation of Warfarin Anticoagulant Therapy |
| |
- |
Introduction of Thromboelastography for Monitoring Haemostatic Function during Pseudomyxoma Peritonei Surgery |
| Neels JG |
- |
Auto-Amplification of TNF-Alpha: A Potential Mechanism for the Maintenance of Elevated TNF-Alpha in Male But Not Female Obese Mice |
| |
- |
Expression, Regulation and Functional Significance of KC Chemokine During Adipose Development and Obesity |
| Neer C |
- |
Cyclosporine Reduces the Platelet Inhibitory Effect of Clopidogrel in Cardiac Transplant Patients |
| |
- |
Dose-Dependent Clopidogrel-Atorvastatin Drug–Drug Interaction Determined by Light Transmission Aggregometry |
| Neerman-Arbez M |
- |
Combined Deficiency of Factor V and Factor VIII: Compound Heterozygosity For Two Novel Truncating Mutations in ERGIC53/LMAN1 |
| |
- |
Investigation of Molecular Mechanisms Regulating Fibrinogen Secretion |
| |
- |
Delayed FPA Release from Homophenotypic Aa 16 H (Fibrinogen Kingsport): Major b Fibrin Epitope Role in Clotting Times and Branching |
| |
- |
Heterozygosity for a Novel FGG Trp253Cys Mutation Causes Hypofibrinogenemia by Specifically Impairing Fibrinogen Secretion |
| |
- |
Genetic and Phenotypic Analysis of Families with Inherited Hypo- and Dys-fibrinogenemia |
| Neff P |
- |
The Use of Recombinant Factor VIIa (rFVIIa) for the Treatment and Prevention of Excessive Bleeding in Non-Hemophiliac Children |
| Neff A |
- |
Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels |
| Negoescu C |
- |
Arterial Thrombosis Complicating Limb Trauma |
| Negrier C |
- |
Selected Human/Porcine Point Substitutions Generated A Human FVIIIa with an Improved Stability |
| |
- |
Combined Type 1 and Type 2N von Willebrand Disease: Contribution of Real Time PCR in Genotype Study |
| |
- |
Genetic Study of 16 Women with Decreased FVIII Level and Assessment of Haemophilia a Carrier Status |
| |
- |
Usefulness of Thromboelastography (ROTEM®) in Coagulation Management in Trauma Patient |
| Négrier C |
- |
Mutations in the Protein C Binding Site of Factor VIII Lead to the Resistance of Activated Protein C Cleavage |
| Negrier C |
- |
Immune Tolerance with FEIBA in a Severe Haemophiliac B with Inhibitor |
| Négrier C |
- |
Usefulness of Thromboelastography (ROTEM) for Treatment Management in a Severe Deficiency FXIII Patient with Inhibitor |
| Negro F |
- |
Identification and Molecular Characterization of a Novel Factor V A2 Domain Tyrosine Deletion Mutation in a Patient with Factor V Deficiency and Bleeding |
| Negrotto S |
- |
Cyclic AMP Protects Stem Cell (CD34+) Apoptosis |
| Negrotto S |
- |
Effects of Leptospiral Proteins on Human Endothelial Cells |
| |
- |
Role of Human Polymorphonuclear Neutrophils in Endothelial Cell Damage Induced by Shiga Toxin-1 and Inflammatory Agents |
| |
- |
Regulation of Megakaryocyte Generation by Monocytes/Macrophages |
| Nehmiz G |
- |
Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Dabigatran in a Dose Finding Trial in Atrial Fibrillation |
| Neisser-Svae A |
- |
Viral Safety of a Novel von Willebrand Factor and Factor VIII Concentrate (Wilate®): Virus Inactivation Capacities of Optimised Solvent/Detergent and Terminal Dry-Heat Treatment |
| |
- |
Protein-Biochemical Characterisation of Wilate®: Determination of the Upper Residual Moisture Limit during Terminal Dry-Heat Treatment |
| |
- |
Terminal Dry-Heat (TDH) Treatment, As Part of the Octanate® Production Process, Contributes to the High Virus Safety Preserving the Structural and Functional Properties of the Concentrate |
| Neisser-Svae1 |
- |
Characterisation of the Novel, High Purity, Double Virus Inactivated von Willebrand Factor and Factor VIII Concentrate Wilate |
| Nekolová J |
- |
Our Experiences with the Determination of ProC Global Test and with the Interpretation of Results |
| Nekoo A Amini |
- |
Study Of TFPI T-287C Polymorphism in Relation to Venous Thrombosis; Association/Functional Analyses and Characterization of TFPI Promoter |
| Nelander K |
- |
Human Aortic Endothelial Cells Inhibit Thrombin Generation in vitro and Augment Inhibition by Melagatran |
| Nelissen RGHH |
- |
Increased Risk of Venous Thrombosis after Orthopedic and General Surgery. Results of the MEGA Study |
| Nelsestuen GL |
- |
Proteomic Analysis of Platelets and Platelet-Derived Microparticles by iTRAQ Labeling and Mass Spectrometry |
| |
- |
Plasma Proteomics in Human Endotoxemia: A Novel Approach Using MALDI-TOF Profiling and iTRAQ Labeling Reveals Oxidation Of Plasma Proteins and Other Significant Changes |
| Nelson D |
- |
The Utility of TGN 255 in a Model of Coronary Pulmonary Bypass and Simulated Mitral Valve Repair in the Dog |
| Nelson-Piercy C |
- |
Low-Molecular-Weight Heparins for Prophylaxis and Treatment of Venous Thromboembolism in Pregnancy: A Systematic Review of Safety and Efficacy |
| Nemerson Y |
- |
Role of Phospholipids in the Activation of F.X By Tissue Factor : VIIa |
| |
- |
Expression of TFPIb in Normal Human Tissues and Inhibitory Activity on Tissue Factor-Initiated Coagulation Reactions by Recombinant TFPIb from Transfected CHO Cells and Escherichia Coli |
| Nemery B |
- |
Macrophage-neutrophil Cross Talk During Pulmonary Exposure to Silica Particles Triggers Peripheral Platelet Activation Via Elastase |
| Nemes L |
- |
The EACH Registry: A Prospective European Registry of Acquired Haemophilia (AH) |
| |
- |
Quality of Life in Patients with Haemophilia – An European Comparison Study (ESCHQoL) |
| |
- |
Immunate S/D – Results of a Phase III, Prospective, Multicenter Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Efficacy of Immunate Solvent Detergent in Previously Treated Patients with Severe or Moderately Severe Hemophilia A |
| Nemmar A |
- |
Macrophage-neutrophil Cross Talk During Pulmonary Exposure to Silica Particles Triggers Peripheral Platelet Activation Via Elastase |
| Nemtsova V |
- |
Relationship Between Oxidative Stress, Endothelial Injury and Coagulation: Activation in Advanced Chronic Heart Failure |
| |
- |
Atorvastatin Inhibits the Expression of Adhesion Molecules on Endothelial Cells by Reducing Reactive Oxygen Species |
| Nenci GG |
- |
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism |
| |
- |
Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement |
| Nepomnaschy I |
- |
Ultralarge Multimers of Von Willebrand Factor (VWF) And ADAMTS13 Activity In Plasma From BALB/C And C57Bl/6J Mice At Physiological Conditions |
| Nesbitt XX |
- |
Importance of Temporal Flow Gradients and Integrin aIIbb3 Mechanotransduction for Shear-Activation of Platelets |
| Nesheim ME |
- |
Further Evidence for Ping-Pong-Like Mechanism for Prothrombinase from Analysis of the Time Courses of Prothrombin, Meizothrombin, Prethrombin-2, and Thrombin During Prothrombin Activation |
| |
- |
The Mechanism of Alpha-1-Protease Inhibitor Inactivation During Sepsis-Induced Disseminated Intravascular Coagulation |
| |
- |
TAFIa Treatment of High Molecular Weight Fibrin Degradation Products Reduces the Ability of Plasminogen to Protect tPA from Inhibition by PAI-1 |
| |
- |
The Time Courses of Fibrin Formation, Prothrombin Activation and TAFI Activation in Normal and Factor VIII-Deficient Plasma |
| Neshiem ME |
- |
Inactivation of Factor V during Sepsis-Induced Disseminated Intravascular Coagulation: Reconciliation of Total Factor V Activity with Its Cleavage and Inactivation as Assessed by SDS-PAGE and Immunoblotting |
| Nesland JM |
- |
RNA Interference Targeting Tissue Factor in a Murine Melanoma Metastasis Model |
| Nestoridi E |
- |
Do Detached Endothelial Cells and Microparticles Contribute to the Procoagulant Activity Observed in Hemolytic Uremic Syndrome? |
| Nestoridi E |
- |
Real-Time Imaging of Tissue Factor-Positive Microparticles in Flowing Blood |
| Neto GCG |
- |
Incidence of Factor VIII Inhibitor in Hemophilia ‘A’ in Ceara – Brazil |
| Neuerburg I |
- |
Usefulness of a Particle Gel Immunoassay (PaGIA) for Rapid Diagnosis of Heparin-Induced Thrombocytopenia |
| Neuvonen PJ |
- |
Acetaminophen Inhibits Platelet Function Dose-dependently in Volunteers |
| Neville B |
- |
Argatroban Interactions with Low Molecular Weight Heparins: Pharmacologic Implications |
| |
- |
Nitric Oxide Generation During Parenteral Administration Differentiates Argatroban from Lepirudin and Bivalirudin |
| |
- |
Comparison of the Anticoagulant Properties of BAY 59-7939 – An Oral, Direct Factor Xa Inhibitor – with Fondaparinux and Enoxaparin |
| |
- |
Down-Regulation of Inflammatory Markers after Treatment with Topically Administered Mucopolysaccharide Polysulfate in Primates |
| |
- |
Interaction of BAY 59-7939 – A Novel, Oral, Direct Factor Xa Inhibitor – with Antiplatelet Agents: Monitoring and Therapeutic Applications |
| |
- |
Effect of 1,6-Anhydro Bicyclic Ring Structure on the Pharmacokinetic and Pharmacodynamic Behavior of Low Molecular Weight Heparin |
| |
- |
Biochemical and Pharmacologic Profiling of a Novel Dual Acting Antithrombin Agent with Antiprotease and Antiplatelet Actions |
| |
- |
Ex vivo Evaluation of the Pharmacodynamic Effects of Defibrotide. Results from Various Clinical Trials |
| |
- |
Antithrombotic Mechanism of Action of BAY 59-7939 – a Novel, Oral, Direct Factor Xa Inhibitor |
| |
- |
Modulation of Inflammatory Markers after Treatment with Topically Administered Mucopolysaccharide Polysulfate. Results of a Study in Primates |
| Nevins J |
- |
Gene Expression Profiling in Antiphospholipid Syndrome Reveals Distinct Molecular Signatures with Diagnostic Value |
| New C |
- |
Venous Thromboembolism and Spinal Surgery |
| Newall F |
- |
Multi Modal Management of Purpura Fulminans due to Homozygous Protein C Deficiency |
| Newall F |
- |
Optimising Anticoagulant Management Strategies through the Use of Validated Educational Interventions |
| Newall F |
- |
Tissue Factor Pathway Inhibitor (TFPI) Contributes to the Early Anticoagulant Effect of Unfractionated Heparin (UFH) during Haemodialysis |
| |
- |
Heparin Monitoring During Haemodialysis in Children |
| |
- |
Tissue Factor Pathway Inhibitor (TFPI) during Heparin Therapy in the Paediatric Intensive Care Unit (PICU) |
| |
- |
Developmental Haemostasis and Response to Heparin Therapy in Children |
| |
- |
Chromogenic and Clot Based Protein C Assays Contribute to the Management Of Homozygous Protein C Deficient Patients |
| Newall F |
- |
Incidence of Major Bleeding in a Large Paediatric Cohort of Patients Requiring Warfarin Therapy |
| Newby D |
- |
Endothelial Progenitor Cells Are Mobilized Following Coronary Angiography |
| Newhart A |
- |
Results of the Master Lot Calibration of a New Coagulation Monitoring System for Patient Self Testing |
| |
- |
INR Results of the CoaguChek® PT Test Compare Well with INR Results of International Reference Thromboplastins |
| Newman PJ |
- |
Regulation of Vascular Cell Activation by PECAM-1 |
| Newman DK |
- |
Immunodepletion of GPVI from Human Platelets Circulating in NOD/SCID Mice: Development of a Novel Animal Model for Evaluating the Therapeutic Efficacy of Compounds that Affect Human Platelet Function and Survival |
| Newman PJ |
- |
Immunodepletion of GPVI from Human Platelets Circulating in NOD/SCID Mice: Development of a Novel Animal Model for Evaluating the Therapeutic Efficacy of Compounds that Affect Human Platelet Function and Survival |
| Newman PJ |
- |
Paxillin and Hic-5 Function as Csk Binding Proteins and Regulate SFK Activity in Collagen-stimulated Murine Platelets |
| Newman DK |
- |
Paxillin and Hic-5 Function as Csk Binding Proteins and Regulate SFK Activity in Collagen-stimulated Murine Platelets |
| Newman DK |
- |
Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Negatively Influences Thrombus Formation in Vivo |
| Newman PJ |
- |
Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Negatively Influences Thrombus Formation in Vivo |
| Nezu J |
- |
Factor VIII Mimetic Antibody: (1) Establishment and Characterization of Anti-factor IX/Anti-factor X Bispecific Antibodies |
| Nezu N |
- |
Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice |
| Ng LYW |
- |
Neuro-microenvironment and Neurotrophic Factors Support ex vivo Expansion of Megakaryocytic Progenitor Cells |
| Ng KFJ |
- |
Platelet Function Monitoring by the PFA-100® in Patients Taking Non-Aspirin NSAIDs |
| Ngo TH |
- |
Humanisation of an Antithrombotic Anti-von Willebrand Factor (VWF) Monoclonal Antibody, 82D6A3, by Variable Domain Resurfacing |
| |
- |
Cloning Strategy and Humanization of the Potent Antithrombotic Agent 6B4, an Anti-Glycoprotein Ib Monoclonal Antibody |
| Négrier C |
- |
Clinical Efficacy and Safety Evaluation of ADVATE Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM) During Surgical and Invasive Procedures |
| Nguyen H |
- |
Extremely High Levels of Thrombospondin-1 in a Patient Afflicted with Rheumatoid Arthritis are Correlated with Activation of the Coagulation and Fibrinolytic Systems |
| Nguyen R |
- |
Amiloride Inhibits Urokinase Type Plasminogen Activator-Mediated Proteolytic Activity and Increases Plasminogen Activator Inhibitor Type-1 mRNA Expression in Aortic Vascular Smooth Muscle Cells |
| Nguyen F |
- |
Screening of Factor V Leiden (FVL) and Risk-Assessment of Venous Thrombosis in Non-FVL-Carriers: Comparison of Different Methods for Activated Protein C Resistance (APCR) Measurement |
| Ni H |
- |
Increased Plasma and Platelet Surface Fibronectin in Acute Myocardial Infarction Patients |
| Ni H |
- |
Platelet Aggregation Independent of Von Willebrand Factor and Fibrinogen |
| Nicaud V |
- |
Haemostatic Factors and the Risk of Cardiovascular Death in Patients with Coronary Artery Disease: The AtheroGene Study |
| Nicham F |
- |
A New Fully Automated Functional Assay for TAFI Determination – STA® Stachrom® TAFI |
| Nichelatti M |
- |
Automated VWF : RCo for VWD Diagnosis |
| Nichol JL |
- |
An Open-Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura |
| Nichols WL |
- |
Congenital Platelet ADP Receptor (P2Y12) Deficiency: A Case Report |
| Nichols WL |
- |
Rituximab Treatment of FVIII Inhibitors in Congenital Hemophilia A (cHA) |
| Nichols TC |
- |
Modified Whole Blood Clotting Time Assay Detects Recombinant Human FVIIa and rFVIIa Analog NN1731 in Canine Hemophilia a Blood in a Dose-Dependent Fashion |
| Nichols WL |
- |
Evaluation of Glass versus Plastic Blood Collection Tubes Used in Coagulation Testing |
| |
- |
Sensitivity of Dilute Russell's Viper Venom Time (DRVVT) to Coagulation Factor Deficiency: Effect on Testing for Lupus Anticoagulant |
| Nicola NA |
- |
Molecular Dissection of Platelet Production Via Random Mutagenesis |
| Nicola ED |
- |
Thrombotic Risk in a Romanian Family with Protein S: Deficient Members |
| Nicolaes GAF |
- |
In vitro Characterization of Increased Factor V 1 Form by Factor V R2 Haplotype |
| Nicole F |
- |
The Association Between Diabetes and Venous Thromboembolism in African Americans and Caucasians and the Relationship with Peroxisome Proliferator-Activated Receptor Polymophisms |
| Niederwieser D |
- |
Influence of Platelet Transfusion on Thrombin Generation in Patients with Bone Marrow Transplantation |
| Nielsen J |
- |
A Comparison of the PK/PD of Tinzaparin in Pregnant Women and in Non-Pregnant Healthy Volunteers |
| Nielsen SL |
- |
FVIIa Decreases Surgery-Induced IL-6 Response in Burn Patients Undergoing Excision and Skin Grafting |
| Nielsen JD |
- |
Accuracy and Precision of International Normalized Ratios (INRs) for Two Point of Care Test Systems: Comparison with Laboratory INR Monitoring |
| Nielsen B |
- |
Cellular Immune Responses in Hemophilia. Why do Inhibitors Develop in Some but not All Hemophiliacs? |
| Nielsen LB |
- |
Uremia-specific Effect on the Arterial Media during Development of Uremic Atherosclerosis in apolipoprotein-E Deficient Mice |
| Nielsen MB |
- |
Plasma Lipids and Lipoproteins in Healthy Subjects are Closely Related to INR |
| Nielsen JD |
- |
Prolonged Thromboprophylaxis with Dalteparin May Improve Survival in Patients Operated on for Abdominal Cancer |
| Nielssen B |
- |
A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients |
| Niemann S |
- |
Prothrombotic Tendency upon Inflammatory Conditions – Alpha Defensins (HNP-1/2/3) Are Strong Platelet Agonists |
| |
- |
New Function for Protease Inhibitors – Alpha1 Antitrypsin and Antithrombin III Inhibit the Activation of Platelets by Alpha Defensins from Neutrophils |
| Niemi TT |
- |
Acetaminophen Inhibits Platelet Function Dose-dependently in Volunteers |
| Niepmann M |
- |
Extracellular Nucleic Acids Serve as Novel Cofactors for Blood Coagulation Via Contact Pathway Activation |
| Niers TM |
- |
Effect of Modified Normothrombotic Heparin on Cancer Progression and Metastasis |
| Niers TM |
- |
Interleukin-10, Interleukin-6, and Interferon-g in Advanced Malignancy: Prognostic Relevance and Impact of Low-Molecular-Weight Heparin Administration |
| Nieswandt B |
- |
Coagulation Factor XII is Essential for Arterial Thrombus Formation in Vivo |
| |
- |
Platelets in Atherothrombosis: Lessons from Mouse Models |
| |
- |
Inhibition of Protein Kinase C Results in an Altered Thrombus Phenotype with Suppressed Platelet Aggregation and Increased Platelet Procoagulant Activity |
| |
- |
Two-Phase Antithrombotic Protection after Anti-GPVI Treatment in Mice |
| |
- |
Inhibition of Platelet Glycoprotein Ib (GP Ib) by a Monoclonal Antibody Prevents Platelet Dependent Thrombosis in Mice |
| |
- |
Crucial Role of Glycoprotein VI in Thrombus Formation and Coagulation during Venous and Arterial Thrombosis |
| |
- |
Diverging Signaling Events Control the Pathway of GPVI Down-Regulation in vivo |
| |
- |
Reduced Thrombus Stability in Mice Lacking the a2A-Adrenergic Receptor |
| |
- |
Role of Integrin a2b1 in Thrombus Stabilization and Embolization |
| Nieto MA |
- |
Hemostatic Abnormalities in Oncolgic Patients |
| Nieuwdorp M |
- |
Acute Hyperglycemia Perturbs Endothelial Glycocalyx and Induces a Prothrombotic State in Healthy Volunteers |
| Nieuwenhuizen W |
- |
Development of a New Test for the Global Fibrinolytic Capacity in Blood |
| Nieuwland R |
- |
Congenital Deficiency of Factor XIII Caused by Two Missense Mutations in a Dutch Family |
| |
- |
The Phospholipid Composition of Cell-derived Microparticles Changes in the Postprandial State |
| |
- |
In Type 2 Diabetes, P-Selectin- But Not CD63 -Exposing Microparticles Are Elevated in the Postprandial State |
| |
- |
Complement Activation on the Surface of Cell-Derived Microparticles in Rheumatoid Arthritis |
| |
- |
P-selectin- and CD63-Exposing Platelet Microparticles Reflect Platelet Activation in Peripheral Arterial Disease and Myocardial Infarction |
| |
- |
Microparticle-associated P-selectin Is a Marker of Platelet Activation in Preeclampsia |
| |
- |
Synovial Microparticles in Arthritic Patients Support Coagulation and Inflammation |
| |
- |
Microparticles From Preeclamptic Patients Do Not Affect Transcription of Inflammation-related Genes in Endothelial Cells |
| |
- |
Inhibition of Microparticle Release from Endothelial Cells Induces Apoptosis |
| |
- |
Cell-derived Microparticles Contain Caspase 3 in Vitro and in Vivo |
| Nieva J |
- |
An Open-Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura |
| Niewiarowska J |
- |
Downregulation of Angiogenesis by DNAzymes to b1 mRNA Integrin Subunit |
| Nigro A |
- |
Cerebral Sinovenous Thrombosis during L-Asparaginase Treatment |
| |
- |
Should Asymptomatic Children with Hereditary Haemorrhagic Telangiectasia (HHT) Be Screened for Vascular Malformations? |
| Niimi S |
- |
Regulation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Gene Expression in Growth-Promoted Hepatocytes and Role of TAFI in Liver Regeneration |
| Niinobu T |
- |
Pulmonary Thromboembolism in Cancer Patients Autopsied in a Japanese General Hospital |
| Niitsu Y |
- |
CS-747 (Prasugrel, LY640315), a Novel Antiplatelet Agent, Inhibits Arterial Thrombosis Through Selective Blockade of Platelet P2Y12 Receptors |
| Nijkeuter M |
- |
The Distribution Of Central, Segmental And Sub-Segmental Pulmonary Emboli In Multi- And Single-Row Helical CT |
| |
- |
Resolution of Pulmonary Thrombo-embolism in Patients with Pulmonary Embolism; A Systematic Review |
| Nikas D |
- |
Antithrombotic Effect of the Peptide YMESRADR, Corresponding to Residues 313–320 of the Platelet aIIb Subunit in a Rabbit Model of Carotid Artery Thrombosis |
| Nikolskaya K |
- |
Coagulation and Anticoagulan Factors in Combined Action of Informational Overload and Weak Static Magnetic Field |
| Nilsen D |
- |
Specific Forms of Activated Factor XII in Citrated Plasma Increase Following Percutaneous Coronary Intervention (PCI) |
| Nilsen DWT |
- |
Plasma Concentrations of Soluble Fibrin, D-dimer, Myeloperoxidase and Pregnancy Associated Plasma Protein A before and after Treatment with PCI or Thrombolysis for Acute Myocardial Infarction |
| Nilsen DW |
- |
Activated Factor XII Provides Better Short-term Prognostic Information for a Subsequent Troponin-T Positive Event than other Biomarkers in Patients with Myocardial Infarction |
| |
- |
Changes in Concentration of Specific Forms of Activated Factor XII Are Observed Following Thrombolytic Therapy with Tenecteplase |
| Nilsson S |
- |
Fibrinolytic Gene Polymorphism and Ischemic Stroke |
| |
- |
C-reactive Protein Polymorphisms and Ischemic Stroke |
| Nilsson B |
- |
Tissue Factor Is Associated with a Negative Outcome of Clinical Islet Transplantation |
| Nilsson C |
- |
APC-PCI Complex Concentration and Association with Factor V Leiden in Patients with Deep Vein Thrombosis |
| |
- |
In vitro and in vivo Monitoring of Fondaparinux with a Viscoelastic Test |
| Nilsson B |
- |
Composite Islet-Endothelial Cell Grafts: A Novel Approach to Counteract Innate Immunity in Islet Transplantation |
| |
- |
Heparinization of the Pancreatic Islet Surface as a Mean to Reduce Harmful Blood Clotting after Intraportal Islet Transplantation |
| Nilsson-Ekdahl K |
- |
Tissue Factor Is Associated with a Negative Outcome of Clinical Islet Transplantation |
| Ninet J |
- |
MIP-1b and VE-Cadherin Are Implicated in Acute Rejection in Human Heart Transplantation |
| Nishida Y |
- |
Elevated Platelet Delivered Microparticles and Lesion Morphology in Acute Coronary Syndrome |
| Nishihira K |
- |
Inhibition of 5-Hydroxytriptamine2A (5-HT2A) Receptor Prevents Occlusive Thrombus Formation on Neointima of Rabbit Femoral Artery |
| Nishihira K |
- |
Detection of von Willebrand Factor and Tissue Factor in Platelets-Fibrin Rich Coronary Thrombi Causing Acute Myocardial Infarction |
| Nishikawa Y |
- |
Pulmonary Thromboembolism in Cancer Patients Autopsied in a Japanese General Hospital |
| Nishimura T |
- |
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Regulates Activated Complement C5a in vivo |
| Nishio M |
- |
Endoplasmic Reticulum-Associated Degradation of Naturally Occurring Protein C and Plasmin Inhibitor Mutants |
| Nishioka J |
- |
A Simple Technique to Determine Thrombopoiesis Level Using Immature Platelet Fraction (IPF) |
| |
- |
Protein C Inhibitor Plays a Role as a Potent Regulator of Activated Hepatocyte Growth Factor Activator |
| |
- |
High Mobility Group Box Protein Is Increased in the Plasma and May Have a Role in Development of Organ Failure in DIC |
| |
- |
Mechanism of Lipopolysaccharide-induced Decrease of Plasma Protein S: Its Expression in Hepatocytes and Sinusoidal Endothelial Cells Is Mediated by NFkB Activation |
| Nishiwaki K |
- |
Standardization of Assays for Plasma Fibrin-Fibrinogen Degradation Products |
| Nizankowska E |
- |
Venous Thromboembolism, Arterial Thrombosis and Plasma Homocysteine Levels in Families with Inherited Thrombophilia |
| Nobori T |
- |
A Simple Technique to Determine Thrombopoiesis Level Using Immature Platelet Fraction (IPF) |
| |
- |
Proteinase 3 Expression on Neutrophil Membranes from Patients with Infectious Disease |
| Nobori N |
- |
High Mobility Group Box Protein Is Increased in the Plasma and May Have a Role in Development of Organ Failure in DIC |
| Noguchi M |
- |
Increased Levels of Hepatocyte Growth Factor in Patients with DIC |
| Noguera C |
- |
Catastrophic Antiphospholipid Syndrome and Kikuchi-Fujimoto Disease: The First Case Reported |
| Noguti MAE |
- |
The Behavior of Anticardiolipin Antibodies Levels in Patients with Venous Thromboembolism |
| Nogutti MAE |
- |
Anticardiolipin Antibodies (ACL), Factor V Leiden (FVL) and G20210A Prothrombin Mutation (G20210AII) Do Not Predispose Renal Transplant Recipients to Thrombotic Complications or Graft Loss |
| Nokes TJC |
- |
Unique Patient Pathway for a Nurse-led DVT Clinic |
| |
- |
Laboratory Investigation for Lupus Anticoagulant (LA) Experience of a Large General Hospital |
| Nokes TJC |
- |
The Development of a VTE Risk Management Protocol for Orthopaedic Patients within a large General Hospital |
| Nold M |
- |
Effect of Protein C and Activated Protein C on Alveolar Fibrin Deposition and Turnover in a Piglet Model of Septic Shock |
| Nolen JDL |
- |
Flow Cytometric Analysis of Platelet Activation Via Recombinant Factor VIIa |
| |
- |
Reproducibility and Utility of a Flow Cytometric-Based Annexin V Competition Assay for Evaluation of the Antiphospholipid Syndrome |
| Nolli S |
- |
Aspirin and Clopidogrel Resistance: A Study on 96 Healthy Volunteers and Role of the P2Y12 H1/H2 Gene Polymorphism |
| Nomikou E |
- |
References Values of roTEM Instrument |
| Nomura S |
- |
Elevated Platelet Delivered Microparticles and Lesion Morphology in Acute Coronary Syndrome |
| Nonaka T |
- |
Aspirin Resistance Detected with Aggregometry Can Not Be Explained by Failure to Suppress Cyclooxygenase Activity: Possible Involvement of Other Signaling Pathway(s) in Cardiovascular Events of Aspirin-treated Patients |
| Nongnuch S |
- |
Homocysteine and Thrombosis in Thai Children: A Case-Control Study |
| Nonne C |
- |
Specific Role of the GPVI/FcRg Complex in Promoting Thrombus Formation Following Superficial But Not Deep Arterial Injury |
| |
- |
Mice Lacking the Platelet Glycoprotein Ib Beta Intracellular Domain Display Resistance to Thrombosis But Normal Bleeding Times |
| Noppe W |
- |
Production of Anti-ADAMTS-13 Monoclonal Antibodies by DNA Immunization |
| Norengaard L |
- |
Visualization of the Continuous APTT Coagulation Signature – Methods and Correlations to Continuous Thrombin Generation |
| |
- |
Haemostatic Potential of a Novel Analogue of rFVIIa Versus rFVIIa on Dynamic Whole Blood Clot Formation in Blood from Patients with Severe Haemophilia A |
| Norhammar A |
- |
Effects of Improved Metabolic Control on Platelet Reactivity in Patients with Type 2 Diabetes Mellitus Following Coronary Angioplasty |
| Norikazu Y |
- |
Diagnosis of Deep Vein Thrombosis by Soluble Fibrin or D-dimer |
| Noris P |
- |
Both Haploinsufficiency and Dominant Negative Effect Are Responsible for Hematological Abnormalities of Patients with 
-Related Disease |
| Norman KE |
- |
Evidence of Partial P2Y12 Receptor Antagonism Despite Excess Clopidogrel in Mice |
| Norman PE |
- |
Enhanced Antiplatelet Effect of Clopidogrel in Patients with Aspirin Resistance: A Randomized Crossover Trial |
| Normandin D |
- |
Elevation of Thrombotic Biomarkers Reveals the Prothrombotic State of Genetically Diabetic (db/db) and Obese (ob/ob) Mice |
| Nossent AY |
- |
Effects of Arginine Vasopressin 2 Receptor Polymorphisms on von Willebrand Factor and Factor VIII Levels and the Risk for Venous Thrombosis |
| |
- |
Effects of Arginine Vasopressin 2 Receptor Polymorphisms on von Willebrand Factor and Factor VIII Levels and the Risk for Venous Thrombosis |
| |
- |
Association of Coagulation Factor VIII Haplotypes with Factor VIII Activity and the Risk of Venous and Arterial Thrombosis |
| Notebeart E |
- |
Prospective Sensitivity Comparison of Three Different D-Dimer Assays for Venous Thromboembolic Disease Exclusion Using a Standardized Diagnostic Algorithm |
| Notley CRP |
- |
The Mutational Spectrum of Type 1 Von Willebrand Disease (VWD): Results from the Canadian Type 1 VWD Study |
| |
- |
Understanding the Genotype/Phenotype Link in Type 1 von Willebrand Disease (VWD): Results from The Canadian Type 1 VWD Study |
| Notø ATW |
- |
Increased Coagulation Activation in Persons with Echogenic Carotid Plaques |
| Notoya A |
- |
Factor VII Arg277His Mutation Induced Discrepancy of Factor VII Activity Levels Using Tissue Factor from Different Sources |
| Novacek G |
- |
Venous Thromboembolism in Inflammatory Bowel Disease: The Pathogenetic Role of Tissue Factor Exposing Microparticles |
| Novak P |
- |
Clinical Phenotype of Hemophilia and Prothrombotic Gene Mutation |
| Nováková IRO |
- |
Relevance of Very Low Titres of Factor VIII Inhibitors in Nijmegen-Bethesda Assay-Negative Patients |
| |
- |
13 Novel Mutations in the Factor VIII Gene in the Nijmegen Hemophilia A Patient Population |
| |
- |
Screening Fibrinolytic Disorders with the Nijmegen Haemostasis Assay |
| |
- |
von Willebrand Factor in Platelets |
| |
- |
Administration of Recombinant Activated Factor VII Causes Activation of Integrin aIIbb3 on Blood Platelets both in vivo and in vitro, Lowering the Threshold for Activation by Thrombin |
| Novakova IRO |
- |
Predictive Value of the Platelet Function Analyser (PFA-100®) for Post Biopsy Bleedings in Patients Undergoing Renal Biopsy |
| Nováková IRO |
- |
The Importance of the Low-Density Lipoprotein Receptor-Related Protein (LRP) and Megalin Receptor in the Clearance of Factor VIII in Humans |
| Novakova I |
- |
The Nijmegen Haemostasis Assay to Study the Interplay between Coagulation and Fibrinolysis |
| Nováková IRO |
- |
Low Amounts Of rVIIa Are Sufficient to Trigger Initiation of Thrombin Generation in Factor VII Deficient Patients |
| |
- |
Discrepancy between FVIII Activity Peak Levels and Thrombin and Plasmin Generation in Severe Hemophilia A Patients Treated with FVIII |
| Novakovic I |
- |
Homocysteine Levels and MTHFR C677T Genotypes in Patients with Myocardial Infarction under Age 45 years |
| Novelli BA |
- |
Type 2 Diabetes: Endothelium Lesion and Fibrinolytic System Markers Assessment |
| |
- |
Natural Anticoagulation Evaluation in Type 2 Diabetes |
| |
- |
Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Plasma Levels of Homocysteine in Patients with Type 2 Diabetes |
| Noventa F |
- |
The Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Patients with Acute Deep Vein Thrombosis or Pulmonary Embolism. A Multicentre Prospective Cohort Study in 1626 Patients |
| Novikova A |
- |
The New Single Nucleotide Polymorphisms of Adp Receptor P2y12 Gene Affected Platelet Aggregation and Myocardial Infarction Development Were Found in Russia |
| Nováková IRO |
- |
DDAVP Treatment Is Not Recommended in Patients with von Willebrand Disease Type 2N |
| |
- |
Platelet Function Analyser Is a Good Alternative for Classical Bleeding Time to Detect von Willebrand Disease and Thrombocytopathy |
| Novokhatny V |
- |
Production and Characterization of a Novel, Recombinantly-modified Plasmin Molecule |
| Novokmet SS |
- |
Platelets/Endothelium Interaction and Oxidative Stress in Isolated Guinea-Pig Heart: Focus on L-Arginine/ No System and Superoxide Anion Radical Production |
| Nowak T |
- |
Nanofiltration Removes Virus Infectivity But Not NAT/PCR Signal for a Wide Range of Viruses |
| Nowak-Goettl U |
- |
High Levels of Lp(a) in Complicated Pregnancies and Women with Recurrent Fetal Loss and Successful Treatment with Dalteparin |
| Nowak-Göttl U |
- |
Elevated Alpha 1-Antitrypsin Is a Risk Factor for Arterial Ischemic Stroke in Childhood |
| |
- |
Risk of Recurrent Venous Thromboembolism in Children with Cerebral Venous Thrombosis – A Prospective Follow-Up Cohort Study |
| |
- |
Long-Term Safety and Efficacy Data on Neonatal Thromboembolism Treated with Dalteparin or Enoxaparin: A Comparison of Once Daily Versus Twice Daily Administration |
| Nowak-Göttl U |
- |
Recurrent Stroke: The Role of Prothrombotic Disorders |
| Noya MS |
- |
Oral Anticoagulant Treatment (OAT) with Portable PT Monitor in Primary Health Care Centres with Immediate Dose Adjustment by the Hospital OAT Unit |
| Nsoure Obame F |
- |
Factor X Gene Mutations Affecting the Gla Domain of the Protein |
| Næss IA |
- |
Anticardiolipin Antibodies and Risk for Venous Thrombosis in a Population-Based Prospective Study |
| N'Tita K |
- |
Different Thromboprophylaxis Approaches in Patients Undergoing Knee Arthroscopy (KANT Study): A Prospective Randomized Study |
| Nugent DJ |
- |
The Use of Recombinant Factor VIIa (rFVIIa) for the Treatment and Prevention of Excessive Bleeding in Non-Hemophiliac Children |
| |
- |
Pilot Dose Finding and Pharmacokinetic Study of Bivalirudin in Infants with Thrombosis |
| |
- |
FCGR3A Genotype Affects the Platelet Response to Immune Globulin (Ig) Treatment of Acute Immune Thrombocytopenic Purpura (ITP) in Children |
| Nunes C |
- |
Anticoagulation Therapy in the Osteonecrosis |
| Nunes FC |
- |
807C/T Polymorphism in the Platelet Glycoprotein Ia Gene in Patients with Ischemic Stroke (IS) of Undetermined Etiology |
| Nuñez R |
- |
Factor VIII Inhibitors in Mild Haemophilia A. Incidence in Patients with Arg2150His Mutation in South of Spain |
| Nurden AT |
- |
Qualitative Disorders of Platelets and Megakaryocytes |
| Nurden P |
- |
Molecular Basis of MYH9-Related Disorders in a Series of Ten Families |
| |
- |
A Novel Case of Familial Thrombocytopenia with Evidence for a Critical Role of Proteins Involved in Ca2+ Signaling in Megakaryocytopoiesis |
| Nurden A |
- |
A Novel Case of Familial Thrombocytopenia with Evidence for a Critical Role of Proteins Involved in Ca2+ Signaling in Megakaryocytopoiesis |
| Nurden P |
- |
Microarray Analysis on Platelet RNA of a Patient with a 22q11 Microdeletion Including the Gpibbeta Gene and Associating Digeorge Syndrome, Moderate Thrombocytopenia and Large Platelets |
| Nurden A |
- |
Microarray Analysis on Platelet RNA of a Patient with a 22q11 Microdeletion Including the Gpibbeta Gene and Associating Digeorge Syndrome, Moderate Thrombocytopenia and Large Platelets |
| Nurmohamed MT |
- |
Short and Long-term Prevention of Venous Thromboembolism. The Dutch Surgical Practice |
| Nurse T |
- |
Anticoagulant Adverse Events in a Major City Hospital |
| Nussberger J |
- |
Inhibition of the Renin-Angiotensin System Does Not Reduce Platelet Activity at Rest or during Stress in Essential Hypertension |
| |
- |
Impaired Bradykinin Response to Ischemia and Exercise in Patients with Mild Congestive Heart Failure During Angiotensin-Converting Enzyme Treatment. Relationships with Endothelial Function, Coagulation and Inflammation |
| Nutescu E |
- |
Barriers to Appropriate Anticoagulation with Warfarin in Orthopedic Surgery |
| Nylænde M |
- |
Markers of Vascular Inflammation Are Associated with the Degree of Atherosclerosis Assessed as Angiographic Score and Treadmill Walking Distance in Patients with Peripheral Arterial Occlusive Disease |
| Nylander S |
- |
Characterisation If Species Differences in the Platelet Thrombin/ADP Response |
| Nyström P |
- |
Prothrombotic Risk Assessment of Patients Receiving Ximelagatran for Secondary Prevention of Venous Thromboembolism |
